Catalyst Wire Dossier Catalyst Wire Dossier

AK3280 cream

· Shanghai Ark Biopharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AK3280 cream, covering 2022-07-06 to 2022-07-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Efficacy of AK3280 Cream on Hypertrophic Scar [Phase 1, Phase 2]

See pricing